These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27575527)

  • 21. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
    Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands.
    de Vries FM; Denig P; Visser ST; Hak E; Postma MJ
    Value Health; 2014 Mar; 17(2):223-30. PubMed ID: 24636380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project.
    van den Oever IAM; Heslinga M; Griep EN; Griep-Wentink HRM; Schotsman R; Cambach W; Dijkmans BAC; Smulders YM; Lems WF; Boers M; Voskuyl AE; Peters MJL; van Schaardenburg D; Nurmohamed MT
    Rheumatology (Oxford); 2017 Sep; 56(9):1472-1478. PubMed ID: 28199724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controversies Regarding Lipid Management and Statin Use for Cardiovascular Risk Reduction in Patients With CKD.
    Markossian T; Burge N; Ling B; Schneider J; Pacold I; Bansal V; Leehey D; Stroupe K; Chang A; Kramer H
    Am J Kidney Dis; 2016 Jun; 67(6):965-77. PubMed ID: 26943983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.
    Persell SD; Brown T; Lee JY; Shah S; Henley E; Long T; Luther S; Lloyd-Jones DM; Jean-Jacques M; Kandula NR; Sanchez T; Baker DW
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):560-6. PubMed ID: 26555123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan.
    Teramoto T; Uno K; Miyoshi I; Khan I; Gorcyca K; Sanchez RJ; Yoshida S; Mawatari K; Masaki T; Arai H; Yamashita S
    Atherosclerosis; 2016 Aug; 251():248-254. PubMed ID: 27419905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic.
    Rollefstad S; Kvien TK; Holme I; Eirheim AS; Pedersen TR; Semb AG
    Ann Rheum Dis; 2013 Dec; 72(12):1968-74. PubMed ID: 23264359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular risk stratification in overweight or obese patients in primary prevention. Implications for use of statins.
    Masson W; Lobo M; Huerín M; Molinero G; Manente D; Pángaro M; Vitagliano L; Zylbersztejn H
    Endocrinol Nutr; 2015 Feb; 62(2):83-90. PubMed ID: 25573227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
    Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease.
    Petersson U; Ostgren CJ; Brudin L; Nilsson PM
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):536-40. PubMed ID: 19357517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid abnormalities and cardiovascular risk in the elderly.
    Milionis HJ; Elisaf MS; Mikhailidis DP
    Curr Med Res Opin; 2008 Mar; 24(3):653-7. PubMed ID: 18218195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16.
    Mehta S; Wells S; Grey C; Riddell T; Kerr A; Marshall R; Ameratunga S; Harrison J; Kenealy T; Bramley D; Chan WC; Thornley S; Sundborn G; Jackson R
    Eur J Prev Cardiol; 2014 Feb; 21(2):192-202. PubMed ID: 23033546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid-lowering pharmacotherapy in Central and Eastern European countries in cardiovascular prevention: self-reported prescription patterns of primary care physicians.
    Tomasik T; Windak A; Seifert B; Kersnik J; Kijowska V; Dubas K
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):234-42. PubMed ID: 23277158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid-lowering treatment in patients at high cardiovascular risk discharged from an Italian hospital.
    Spighi A; Tartagni E; D'Addato S; Dormi A; Borghi C
    J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):270-5. PubMed ID: 22728834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
    Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Thomason MJ; Mackness MI; Charlton-Menys V; Fuller JH;
    Lancet; 2004 Aug 21-27; 364(9435):685-96. PubMed ID: 15325833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of evidence-based therapy for the prevention of cardiovascular events among older people.
    Castelino RL; Chen TF; Guddattu V; Bajorek BV
    Eval Health Prof; 2010 Sep; 33(3):276-301. PubMed ID: 20801973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular risk estimation in older persons: SCORE O.P.
    Cooney MT; Selmer R; Lindman A; Tverdal A; Menotti A; Thomsen T; DeBacker G; De Bacquer D; Tell GS; Njolstad I; Graham IM;
    Eur J Prev Cardiol; 2016 Jul; 23(10):1093-103. PubMed ID: 26040999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoporosis among older Saudis: risk of fractures and unmet needs.
    Amin TT; Al Owaifeer A; Al-Hashim H; Alwosaifer A; Alabdulqader M; Al Hulaibi F; Al Hamam A
    Arch Osteoporos; 2013; 8():118. PubMed ID: 23361436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin.
    Swindle JP; Potash J; Kulakodlu M; Kuznik A; Buikema A
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):471-82. PubMed ID: 22019005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Benefits and risks for primary prevention with statins in the elderly].
    Joseph JP; Afonso M; Berdaï D; Salles N; Bénard A; Gay B; Bonnet F
    Presse Med; 2015 Dec; 44(12 Pt 1):1219-25. PubMed ID: 26585744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.